Among the 11q13-amplified cancer samples that carry amplification of SHANK2 and/or Cyclin D1, 233 amplified both SHANK2 and Cyclin D1, 412 amplified only SHANK2 and 50 amplified only Cyclin D1 (Fig. 7C and Table S3). Here, CCND1 is linked to cancer.